Crown Bioscience
Cambridge, United Kingdom· Est. 2006
Advance translational oncology with Crown Bioscience, a full-service CRO delivering comprehensive preclinical and oncology CRO services worldwide.
Private Company
Total funding raised: $54M
About
Advance translational oncology with Crown Bioscience, a full-service CRO delivering comprehensive preclinical and oncology CRO services worldwide.
OncologyMetabolicDrug Delivery
Funding History
3Total raised:$54M
Series C$26MJun 15, 2014
Series B$18MJun 15, 2012
Series A$10MJun 15, 2010